Mouse Valerylfentanyl Carboxylic acid Monoclonal Antibody

Anti Valerylfentanyl Carboxylic acid mouse monoclonal antibody

Cat. Num. AAA41072

• Reactivity: CAS # 117332-91-9
• Applications: ELISA
• Purity: Protein G purified from mice ascites
• Synonyms: Valerylfentanyl Carboxylic acid, Antibody; Anti Valerylfentanyl Carboxylic acid mouse monoclonal antibody; Valeryl fentanyl (hydrochloride); anti-Valerylfentanyl Carboxylic acid antibody

• Host: Mouse
• Reactivity: CAS # 117332-91-9
• Clonality: Monoclonal
• Isotype: IgG1
• Clone Number: 95-F-6
• Purity/Purification: Protein G purified from mice ascites
• Form/Format: Liquid; PBS, pH7.4, containing 0.05% proclin300, 50% glycerol.
• Concentration: 1.53 mg/ml (varies by lot)

• Applicable Applications for anti-Valerylfentanyl Carboxylic acid antibody: ELISA
• Immunogen: Valerylfentanyl Carboxylic acid
• Conjugation: Unconjugated
• CAS#: 117332-91-9
• Dry Ice Shipment: Extra charge fee may add to your shipping cost as dry ice is required to ship this product.
• Preparation and Storage: Use a manual defrost freezer and avoid repeated freeze thaw cycles.; Store at 4°C for frequent use.; Store at -20 to -80°C for 12 months from the date of receipt

Related Product Information for anti-Valerylfentanyl Carboxylic acid antibody

Valerylfentanyl first appeared in toxicological assays in 2016 and through 2018, it has been reported in 6 countries worldwide, including North America, Europe, and Asia. It is being sold as heroin, an adulterant in heroin, or as counterfeit pills. Few fatalities have been attributed to this substance although confiscations of drug containing valerylfentanyl appear to be increasing in some states in the U.S. Receptor binding data show that valerylfentanyl binds selectively to the mu subtype of opioid receptors with low nanomolar affinity relative to kappa and delta opioid receptors. Functional binding assays suggest that valerylfentanyl is a partial agonist at mu and kappa opioid receptors and an antagonist at delta receptors. However, in vivo pharmacology studies in rodents and non-human primates suggest that valerylfentanyl is a full mu agonist.No pharmacokinetic studies of valerylfentanyl are reported in the preclinical or clinical scientific literature. Valerylfentanyl appears to be less potent than other illicit mu agonists with a chemical structure that is similar to fentanyl. As such, its pharmacology and toxic effects are likely to be similar to fentanyl. It currently has no legitimate medical or veterinary uses and is relatively easy to manufacture. The totality of data currently available on valerylfentanyl suggests that it has high abuse potential and poses a serious public health threat.

Product Categories/Family for anti-Valerylfentanyl Carboxylic acid antibody

Primary antibody